OTCMKTS:EPGNY

Epigenomics - EPGNY Stock Forecast, Price & News

$2.39

0.00 (0.00%)

(As of 09/26/2022 12:00 AM ET)

Add

Compare

Today's Range: $2.39
▼
$2.39
50-Day Range: $2.29
▼
$2.80
52-Week Range: $2.01
▼
$2.39

Volume: N/A
Average Volume: 100 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Epigenomics (OTCMKTS:EPGNY) Stock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

EPGNY Stock News Headlines

September 19, 2022 | markets.businessinsider.com

EQS-Adhoc: Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs

September 19, 2022 | uk.finance.yahoo.com

Epigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test

September 19, 2022 | markets.businessinsider.com

EQS-News: Epigenomics Initiates prospective multi-center clinical trial for Next-Generation blood-based colorectal cancer test

September 9, 2022 | markets.businessinsider.com

DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1

August 15, 2022 | uk.finance.yahoo.com

Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG

August 15, 2022 | markets.businessinsider.com

DGAP-News: Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG

August 10, 2022 | markets.businessinsider.com

DGAP-News: Epigenomics AG Reports Financial Results for the First Six Months of 2022

May 11, 2022 | uk.finance.yahoo.com

Epigenomics AG Reports Financial Results for the First Quarter of 2022

May 11, 2022 | markets.businessinsider.com

DGAP-News: Epigenomics AG Reports Financial Results for the First Quarter of 2022

March 30, 2022 | marketwatch.com

Global Personalized Medicine and Epigenomics Market 2022 Opportunity Assessment, Key Drivers and Challenges, Growth Rate and Forecast to 2028

March 24, 2022 | markets.businessinsider.com

DGAP-News: Epigenomics AG Reports Financial Results for Fiscal Year 2021

January 14, 2022 | nasdaq.com

EPGNY After-Hours Quotes

January 6, 2022 | nasdaq.com

EPGNY Real-Time Quotes

November 10, 2021 | markets.businessinsider.com

DGAP-News: Epigenomics AG publishes financial results for the first nine months 2021

September 13, 2021 | uk.finance.yahoo.com

Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

August 17, 2021 | uk.finance.yahoo.com

Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

December 22, 2020 | finance.yahoo.com

Sonim Announces Software Development Relationship with Coforge

December 18, 2020 | finance.yahoo.com

Sonim to Transfer Shenzhen Manufacturing Responsibilities to Unicair

December 8, 2020 | finance.yahoo.com

Sonim XP5s Ultra-rugged Feature Phone Now Supported by Mission-Critical Standards Based FirstNet® PTT Solution from AT&T

December 3, 2020 | marketwatch.com

Epigenomics Market 2020 Global Share, Size, Future Demand, Global Research, Top Leading Players, Emerging Trends, Region by Forecast to 2026

December 3, 2020 | finance.yahoo.com

Do Hedge Funds Love Sonim Technologies, Inc. (SONM)?

November 12, 2020 | finance.yahoo.com

Sonim Technologies to Present at the virtual Fall Investor Summit on November 16th-18th

November 11, 2020 | finance.yahoo.com

Sonim Announces Rugged Handheld and Tablet with Integrated Barcode Scanners

October 21, 2020 | uk.finance.yahoo.com

Epigenomics AG hosts conference call on preliminary CMS reimbursement decision

October 16, 2020 | uk.finance.yahoo.com

Epigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Diagnostics & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:EPGNY
CUSIP: N/A
CIK: N/A
Web: www.epigenomics.com
Phone: (493) 024-3450
Fax: N/A
Employees: 32
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Gregory K. Hamilton (Age 52)
CEO & Member of the Exec. Board
Comp: $794.5k

Dr. Andrew A. Lukowiak Ph.D. (Age 50)
Pres & Chief Scientific Officer
Comp: $371.57k

Mr. Jens Ravens (Age 52)
CFO & Member of Exec. Board

Frederic Hilke
Investor Relations Officer

Dr. Noel Thomas Doheny
Chief Exec. Officer of Epigenomics Inc.

Key Competitors

View All Competitors

EPGNY Stock - Frequently Asked Questions

How have EPGNY shares performed in 2022?: Epigenomics' stock was trading at $3.54 at the start of the year. Since then, EPGNY stock has decreased by 32.5% and is now trading at $2.39.
View the best growth stocks for 2022 here.
What is Epigenomics' stock symbol?: Epigenomics trades on the OTCMKTS under the ticker symbol "EPGNY."

How do I buy shares of Epigenomics?: Shares of EPGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Epigenomics' stock price today?: One share of EPGNY stock can currently be purchased for approximately $2.39.
How can I contact Epigenomics?: Epigenomics' mailing address is Geneststrasse 5, Berlin, Berlin 10829. The official website for the company is www.epigenomics.com. The company can be reached via phone at (493) 024-3450.

This page (OTCMKTS:EPGNY) was last updated on 9/26/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms